Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia

NCT04546893 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

B-ALL

Interventions

BIOLOGICAL: CD19 CAR-T

Sponsor

Hebei Senlang Biotechnology Inc., Ltd.

Collaborators

[object Object]
[object Object]